Cargando…
Cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia
Cold agglutinins are autoantibodies that agglutinate red blood cells at low temperatures, leading to haemagglutination and haemolysis. They are generally of no clinical significance. However, when people with cold agglutinins undergo cardiac operation with hypothermia and cold cardioplegia, they can...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652867/ https://www.ncbi.nlm.nih.gov/pubmed/29021143 http://dx.doi.org/10.1136/bcr-2017-221888 |
_version_ | 1783273144119721984 |
---|---|
author | Ogawa, Tatsuhiko |
author_facet | Ogawa, Tatsuhiko |
author_sort | Ogawa, Tatsuhiko |
collection | PubMed |
description | Cold agglutinins are autoantibodies that agglutinate red blood cells at low temperatures, leading to haemagglutination and haemolysis. They are generally of no clinical significance. However, when people with cold agglutinins undergo cardiac operation with hypothermia and cold cardioplegia, they can experience complications. Thus, different perioperative management is required for such patients. We describe a 74-year-old man with cold agglutinins incidentally detected on the preoperative screening test. He had never experienced any complications or developed a haematological disease. Since cold agglutinins were incidentally detected on the preoperative test, a special strategy was used to manage the temperature of cardiopulmonary bypass (CPB) and cardioplegia. He successfully underwent normothermic cardiac operation with warm cardioplegia. A continuous retrograde hyperkalaemic infusion and intermittent antegrade infusion of warm cardioplegia with normothermic CPB is one of the best methods to avoid hypothermia and excessive activity and metabolism of the heart, and to provide a suitable operative field. |
format | Online Article Text |
id | pubmed-5652867 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-56528672017-10-25 Cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia Ogawa, Tatsuhiko BMJ Case Rep Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation) Cold agglutinins are autoantibodies that agglutinate red blood cells at low temperatures, leading to haemagglutination and haemolysis. They are generally of no clinical significance. However, when people with cold agglutinins undergo cardiac operation with hypothermia and cold cardioplegia, they can experience complications. Thus, different perioperative management is required for such patients. We describe a 74-year-old man with cold agglutinins incidentally detected on the preoperative screening test. He had never experienced any complications or developed a haematological disease. Since cold agglutinins were incidentally detected on the preoperative test, a special strategy was used to manage the temperature of cardiopulmonary bypass (CPB) and cardioplegia. He successfully underwent normothermic cardiac operation with warm cardioplegia. A continuous retrograde hyperkalaemic infusion and intermittent antegrade infusion of warm cardioplegia with normothermic CPB is one of the best methods to avoid hypothermia and excessive activity and metabolism of the heart, and to provide a suitable operative field. BMJ Publishing Group 2017-10-10 /pmc/articles/PMC5652867/ /pubmed/29021143 http://dx.doi.org/10.1136/bcr-2017-221888 Text en © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
spellingShingle | Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation) Ogawa, Tatsuhiko Cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia |
title | Cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia |
title_full | Cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia |
title_fullStr | Cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia |
title_full_unstemmed | Cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia |
title_short | Cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia |
title_sort | cold agglutinins in a patient undergoing normothermic cardiac operation with warm cardioplegia |
topic | Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652867/ https://www.ncbi.nlm.nih.gov/pubmed/29021143 http://dx.doi.org/10.1136/bcr-2017-221888 |
work_keys_str_mv | AT ogawatatsuhiko coldagglutininsinapatientundergoingnormothermiccardiacoperationwithwarmcardioplegia |